Health Catalyst Q2 FY26 net loss narrows 1% to $40.54 million; revenue falls 13% to $70.49 million - HCAT News | RalliesHealth Catalyst Q2 FY26 net loss narrows 1% to $40.54 million; revenue falls 13% to $70.49 million
H
HCAT• Q2 results
- Health Catalyst posted a GAAP net loss of $40.54 million, versus a $40.98 million loss a year earlier.
- Revenue fell 13% year over year to $70.49 million, while GAAP gross margin rose 2 percentage points to 40%.
- Non-GAAP adjusted EBITDA increased 6% to $9.92 million, with adjusted gross margin up 1 percentage point to 51%.
Balance sheet and outlook
- Ben Albert said the company closed the Vitalware divestiture and fully repaid its credit facility debt, strengthening the balance sheet.
- Outlook calls for revenue of $55 million-$56 million in Q3 2026, with non-GAAP adjusted EBITDA of $0-$0.5 million.
•
